COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research.
Sri Harsha KanuriPrapthi Jayesh SirrkayAyse Sena UlucayPublished in: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology (2023)
Taken together, this review builds upon the current literature of COVID-19-induced A-fib, including pathophysiology, clinical presentation, treatment and complications. Furthermore, it provides recommendations for future research moving forward that can open avenues for developing novel remedies that can prevent as well as hasten clinical recovery of atrial fibrillation in COVID-19 patients.
Keyphrases
- atrial fibrillation
- sars cov
- coronavirus disease
- oral anticoagulants
- catheter ablation
- current status
- left atrial
- heart failure
- left atrial appendage
- direct oral anticoagulants
- respiratory syndrome coronavirus
- systematic review
- percutaneous coronary intervention
- risk factors
- high glucose
- drug induced
- liver fibrosis
- clinical practice
- left ventricular
- coronary artery disease
- replacement therapy